Vanguard Global Advisers »

Crinetics Pharmaceuticals In shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 41k 36.32

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
BlackRock
Wellington Management Company
Farallon Capital Management
Driehaus Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Henderson Group
EcoR1 Capital
Geode Capital Management
Baker Bros. Advisors
State Street Corporation
Pictet Asset Management Holding SA
Jennifer Ranahan

View all funds holding Crinetics Pharmaceuticals In